Papers
14
Total Citations
211
H-Index
9
About
Xiaogong Li is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for prostate, kidney, and bladder cancers. His most significant contribution is the development and validation of Retzius-sparing robot-assisted radical prostatectomy (RS-RARP), a posterior approach that dramatically improves early recovery of urinary continence. In a landmark randomized controlled trial (58 citations), Li demonstrated that RS-RARP significantly outperforms conventional anterior approaches, establishing a new standard for functional preservation in prostate cancer surgery. His work further identifies preoperative MRI-based predictors of surgical outcomes, including tumor location and urethral parameters, enabling personalized surgical planning. Beyond prostate cancer, Li has conducted comparative studies of laparoscopic and robot-assisted approaches for adrenal and renal tumors, with notable randomized trials on simple enucleation versus standard partial nephrectomy. His research on robot-assisted radical cystectomy in elderly patients (≥80 years) demonstrates that age alone should not preclude aggressive surgical treatment. With over 200 citations across his most influential papers, Li’s work has fundamentally shaped modern urologic oncology, prioritizing both oncologic control and quality of life through evidence-based surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10